Epilepsy News

Researchers observed no difference in functional neurodevelopment or epilepsy among children aged 24 months regardless of whether antiseizure medication was discontinued or maintained in infants at discharge once seizures ceased.

The American Academy of Neurology released an update to their 2014 position statement on telehealth in which they reiterate their call for expanding its use.

Models provided more accurate predictions of risk for sudden unexpected death in epilepsy than population-based estimates, according to results of a study that utilized a Bayesian logistic regression model.

A study demonstrating that galantamine, a cholinesterase inhibitor, significantly reduced risk for severe dementia over a 5-year period among patients with Alzheimer’s led neurology coverage in April.

Daily administration of Xcopri resulted in high rates of sustained and complete seizure reduction, according to a post hoc analysis of a phase 3, multicenter, open-label study presented at the American Academy of Neurology Annual Meeting.

Children born to women with epilepsy who received antiepileptic drugs during pregnancy displayed similar neurodevelopmental outcomes as children born to healthy women, according to findings from a prospective study.

Status epilepticus incurred “a large burden” on patients and the U.S. health care system over a 3-year study of more than 43,000 hospitalizations, with higher mortality risk and hospital costs as disease refractoriness increased.

The FDA ordered additional studies for Lamictal following a review of current research by the agency that demonstrated the potential for an increased risk for arrhythmias in patients with heart disease who are taking Lamictal.

Researchers have identified “critical pathways” and “novel proteins” that may be considered potential drug targets for patients with epilepsy, according to findings published in bioRxiv.

The FDA approved fosdenopterin injection, a first-in-class treatment to reduce risk for death due to molybdenum cofactor deficiency type A, a rare, genetic, metabolic disorder that typically presents in the first few days of life.